The group’s principal activity is medical technologies company serving the fast-growing diabetes market through its proprietary drug delivery systems Mini-Ject(TM), e-Patch(TM), Micro-Trans(TM), and h-Patch(TM). The group product V-Go(TM) is a simple-to-use, once-daily, disposable insulin delivery device that provides a continuous set basal rate and on-demand bolus dosing for mealtime coverage via a rapid acting insulin analog and h-Patch(TM) technology also being developed to serve as a launching platform for applications across a wide spectrum of medical needs. The group operates from the United States.
